SANTA CLARA, Calif., Oct. 22, 2019 /PRNewswire/ -- Verix Health, formerly Greppo Technologies, announced today the closing of an $8 million Series A financing round led by Ajax Health with participation from Aperture Venture Partners and Western Technology Investment. Verix Health is developing a portfolio of steerable devices enabling minimally invasive delivery of diagnostic and therapeutic tools for solid-organ cancers. The capital will fund ongoing R&D activities and prepare the product line for commercialization.  

"From the beginning, our vision has been to create a platform capable of enabling advanced diagnosis and therapy for a spectrum of diseases," said Sasha Schrode, CEO of Verix Health. "We are honored to have the support of Ajax Health, Aperture and WTI to help us achieve our important mission. Through this collaboration, we believe we are making significant progress toward innovating devices that will have a profound impact on patients."

READ MORE